Epilepsy, Absence clinical trials
The registry lists 24 studies for Epilepsy, Absence across more than 10 countries. 2 are recruiting or about to start. 21 of them are mainly about Epilepsy, Absence (how this is decided). Per ClinicalTrials.gov, last updated 2026-10-30.
Get an email when these change. Save the Epilepsy, Absence studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Who runs them
UCB Biopharma SRL (3) · Eysz, Inc. (2) · Radius Pharmaceuticals, Inc. (2) · Meir Medical Center (1) · Fondation Ophtalmologique Adolphe de Rothschild (1) · Maastricht University Medical Center (1) · Rachel Kuperman (1) · Biohaven Therapeutics Ltd. (1)
What is being tested here
Drugs under test in Epilepsy, Absence studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted
| Drug | Open | Phase 3 | All |
|---|---|---|---|
| BMB-101 | 1 | 0 | 1 |
| Brivaracetam | 0 | 3 | 3 |
| Cannabidiol | 0 | 0 | 2 |
| NPT 2042 | 0 | 0 | 1 |
| Ethosuximide | 0 | 1 | 1 |
| Lamotrigine | 0 | 1 | 1 |
| Valproic Acid | 0 | 1 | 1 |
| Levetiracetam | 0 | 0 | 1 |
| Topiramate | 0 | 0 | 1 |
| Opakalim | 0 | 1 | 1 |
Coming up
Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.
Who these studies take
Of the 2 Epilepsy, Absence studies recruiting now, 0 (0%) set no upper age limit and 2 (100%) stop at 75 or younger. 1 (50%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 0 (0%) take healthy volunteers.
| Age | Women | Men |
|---|---|---|
| 10 | 1 (50%) | 1 (50%) |
| 18 | 1 (50%) | 1 (50%) |
| 30 | 1 (50%) | 1 (50%) |
| 40 | 1 (50%) | 1 (50%) |
| 50 | 1 (50%) | 1 (50%) |
| 65 | 1 (50%) | 1 (50%) |
| 75 | 0 (0%) | 0 (0%) |
| 85 | 0 (0%) | 0 (0%) |
Across all 24 studies, recruiting or not: 79% stop at 75 or younger and 67% at 65; 83% take children; 0% are for women only and 0% for men only; 25% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.
Studies
Recruiting first, then most recently updated. Showing 24 of 24. search them.
- Ketogenic Diet for New-Onset Absence EpilepsyRecruitingNCT04274179Phase 31 country
- BMB-101 in Absence Epilepsy and DEERecruitingNCT06401538Phase 21 country
- A Study to Evaluate the Efficacy, Safety, and Tolerability of Brivaracetam as Monotherapy in Patients 2 to 25 Years of Age With Childhood Absence Epilepsy or Juvenile Absence EpilepsyCompletedNCT04666610Phase 37 countries
- A Study Evaluating NPT 2042 Versus Placebo in Subjects Aged 16-75 Years With Genetic Generalized Epilepsy (GGE) and Absence SeizuresCompletedNCT06769659Phase 21 country
- A Study to Test the Long-term Safety and Tolerability of Brivaracetam in Study Participants With Childhood Absence Epilepsy or Juvenile Absence EpilepsyActive, not recruitingNCT06315322Phase 35 countries
- A Study to Determine if BHV-7000 is Effective and Safe in Adults With Idiopathic Generalized Epilepsy With Generalized Tonic-clonic SeizuresTerminatedNCT06425159Phase 2/314 countries
- A Study to Test the Long-term Safety, Tolerability and Efficacy of Brivaracetam in Study Participants 2 to 26 Years of Age With Childhood Absence Epilepsy or Juvenile Absence EpilepsyCompletedNCT05109234Phase 36 countries
- Assessing Comorbidities in Epilepsy Using Eye Movement RecordingsCompletedNCT063107721 country
- Detecting Absence Seizures Using Hyperventilation and Eye Movement RecordingsCompletedNCT060934901 country
- Objective EEG Bed Side Assessment of Impaired Conscious Awareness in EpilepsyCompletedNCT047997951 country
- Flunarizine for Treatment Resistant Absence EpilepsyTerminatedNCT06153186Phase 21 country
- Cannabidiol Oral Solution in Pediatric Participants With Treatment-Resistant Childhood Absence SeizuresTerminatedNCT03336242Phase 21 country
- Long-Term Safety of Pharmaceutical Grade Synthetic Cannabidiol Oral Solution in Pediatric Participants With Treatment-Resistant Childhood Absence SeizuresTerminatedNCT03355300Phase 21 country
- Mutual Interactions Between Absence Epilepsy Seizures and the Integration of Sensory StimuliTerminatedNCT03676543Not applicable1 country
- Detecting Absence Seizures Using Eye TrackingCompletedNCT044396561 country
- ECV - Epihunter Clinical ValidationCompletedNCT04615442Not applicable4 countries
- Childhood Absence Epilepsy Rx PK-PD-Pharmacogenetics StudyCompletedNCT00088452Phase 31 country
- Longitudinal Early Epilepsy StudyStatus unknownNCT029541071 country
- Search for Genes Influencing Childhood Absence Epilepsy (CAE) StudyCompletedNCT000419511 country
- Does Body Positioning Affect the Yield of Hyperventilation in Routine Pediatric Electroencephalography - EEG Studies?Status unknownNCT02766595Not applicable
- Why Are Patients With Absence Seizures Absent? A Brain Imaging StudyCompletedNCT003936661 country
- A Pilot Study of Efficacy and Tolerability of Levetiracetam Monotherapy in Subjects With Childhood Absence EpilepsyCompletedNCT00361010Not applicable1 country
- A Pilot Study of Topiramate in Childhood Absence EpilepsyCompletedNCT00210574Phase 2
- Transcutaneous Non-invasive Stimulation of the Vagus Nerve for the Treatment of Difficult-to-treat EpilepsyCompletedNCT01178437Not applicable1 country